To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
838 Current news from the ressort finances
rss |
You can refine your search further. Select from the filter options on the left to narrow down your results. |
ALTANA Holds Its Ground in a Challenging Environment and Sets the Course for Further Growth
High investments in international sites and digitization
24-Mar-2020
In the 2019 fiscal year, the specialty chemicals Group ALTANA held its ground in a challenging market environment and at the same time set the course for further growth. Sales amounted to €2,249million and were thus nearly 3percent below the level of the previous year, which was still ...
WACKER Makes Guidance For 2020 Conditional Due to Coronavirus
18-Mar-2020
As already reported, Wacker Chemie AG's total sales for 2019 almost matched the prior-year level. On presenting its annual report, the Munich-based chemical company announced that Group sales came in at €4.93 billion in 2019 (2018: €4.98 billion). The slight decline of 1 percent was mainly due to ...
LANXESS achieves full-year target for 2019 despite challenging environment
Leather business unit reported as a discontinued operation
11-Mar-2020
Specialty chemicals company LANXESS had a successful fiscal year 2019 in an increasingly challenging economic environment. EBITDA pre exceptionals increased by 3.3percent to EUR1.019billion. As guided, the earnings came in roughly in the middle of the range of EUR1.00billion to ...
Merck Meets all Financial Targets and Makes Significant Strategic Progress
06-Mar-2020
Merck met all its financial targets and thus grew profitably in fiscal 2019. At the same time, Merck also made significant progress in executing its strategic agenda. “We delivered on our promise and achieved growth for all our key performance indicators, namely net sales, EBITDA pre and EPS pre. ...
Evonik has kept earnings stable
New company structure mirrors strategy
04-Mar-2020
Evonik has kept earnings stable despite a deteriorating global economy. Adjusted EBITDA in 2019 was €2.153 billion compared with €2.150 billion in the previous year. Sales fell slightly by 1 percent to €13.1 billion. “We achieved our outlook and kept our earnings stable even in a market ...
Brenntag increases profit and intends to raise the dividend
04-Mar-2020
Brenntag generated sales of 12,821.8 million EUR in 2019 in a difficult macroeconomic environment. Sales were therefore on a par with the prior-year figure on a constant currency basis. Operating gross profit rose by 3.4% to just over 2,821.7 million EUR. Operating EBITDA reached 1,001.5 million ...
BASF: EBIT before special items declines
Impacts from coronavirus expected
28-Feb-2020
BASF generated sales of €59.3 billion in the 2019 business year; the slight decline in sales compared with the previous year resulted from lower volumes and prices. Income from operations (EBIT) before special items was €4.5billion, down by €1.7billion from the prior-year level as a result of ...
Bayer strategically and operationally successful
27-Feb-2020
Bayer was strategically and operationally successful last year. “We delivered in 2019 and kept our promises in all areas,” Werner Baumann, Chairman of the Board of Management, said on Thursday at the Financial News Conference in Leverkusen. “We achieved our financial targets despite coming up ...
Covestro achieves targets in continuing challenging market environment
21-Feb-2020
Covestro has achieved its targets in a challenging market environment in fiscal 2019. Core volumes increased by 2.0% compared to the previous year. Group sales fell by 15.1% to approximately EUR 12.4 billion as selling prices remained low due to increased competitive pressure in all segments. ...
Sartorius looks optimistically to 2020
19-Feb-2020
Sartorius confirmed its preliminary figures upon publication of its 2019 Annual Report. Group sales revenue rose in constant currencies by 14.8% (reported: +16.7%) to 1,827.0 million euros. Growth was almost entirely organic as the acquisition of the cell culture media specialist Biological ...
